How a new stratified adaptive phase II design could improve targeting population
Author:
Publisher
Wiley
Subject
Statistics and Probability,Epidemiology
Reference11 articles.
1. A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patient;Pierga;Breast Cancer Research and Treatment,2010
2. An adaptive Simon two-stage design for phase 2 studies of targeted therapies;Jones;Contemporary Clinical Trials,2007
3. One- and two-stage designs for stratified phase II clinical trials;London;Statistics in Medicine,2005
4. One-sample multiple testing procedure for phase II clinical trials;Fleming;Biometrics,1982
5. Targeting population entering phase III trials: a new stratified adaptive phase II design;Tournoux-Facon;Statistics in Medicine,2011
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cross-validated risk scores adaptive enrichment (CADEN) design;Contemporary Clinical Trials;2024-09
2. A stratified adaptive two-stage design with co-primary endpoints for phase II clinical oncology trials;BMC Medical Research Methodology;2022-10-26
3. Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial;Breast Cancer Research;2019-11-14
4. Addressing heterogeneity in the design of phase II clinical trials in geriatric oncology;European Journal of Cancer;2018-11
5. Designing phase II clinical trials to target subgroup of interest in a heterogeneous population: A case study using an R package;Computers in Biology and Medicine;2018-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3